Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024

WINNIPEG, MB / ACCESS Newswire / April 25, 2025 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in…

Medicure Reports Mixed 2024 Results: Q4 Revenue Surges 16% While Key Drug Sales Show Dramatic Shifts

Latest earnings reveal 24% growth in ZYPITAMAG sales to $6.2M, while flagship AGGRASTAT faces headwinds. See full product portfolio performance details.

Sierra Madre Announces Fourth Quarter and Year-End 2024 Financial Results

Vancouver, British Columbia, April 22, 2025 - Sierra Madre Gold and Silver Ltd. (TSXV: SM, OTCQX: SMDRF) ("Sierra Madre" or the "Company" - https://www.commodity-tv.com/ondemand/companies/profil/sierra-madre-gold-silver/) is pleased to announce its audited consolidated financial results for the year ended December 31, 2024 (“FY 2024”) including results for the fourth quarter (“Q4 2024”). All amounts are expressed in U.S. dollars, unless otherwis…